Skip to main content
DaehanPharmaceutical logo

DaehanPharmaceutical — Investor Relations & Filings

Ticker · 023910 ISIN · KR7023910003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2023-01-31 Major Shareholding Noti…
Country KR South Korea
Listing KO 023910

About DaehanPharmaceutical

https://www.dhnp.co.kr/

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by Mirae Asset Global Investments regarding their stake in Daehan Pharmaceutical Co., Ltd. This type of filing is a regulatory requirement for entities that cross specific ownership thresholds in a company's shares. In the context of the provided categories, this fits the definition of a 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2023-01-31 Korean
자기주식취득결과보고서
Transaction in Own Shares Classification · 1% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by the company (Daihan Pharmaceutical Co., Ltd.) over a specified period. This type of filing is a standard regulatory disclosure regarding a company's transaction in its own shares (share buyback).
2023-01-03 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for the purpose of holding an Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the upcoming meeting's administrative requirements. Given its nature as a regulatory notification regarding meeting logistics, it fits best under the RNS category.
2022-12-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report or major shareholding notification). It details the share ownership, changes in holdings, and the purpose of investment by Fidelity Management & Research Company LLC in Daehan Pharmaceutical Co., Ltd. This fits the definition of a Major Shareholding Notification (MRQ).
2022-12-12 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Daehan Pharmaceutical Co., Ltd. (대한약품공업주식회사) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by Mirae Asset Global Investments in Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2022-11-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.